GNMK - GenMark Diagnostics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
7.03
+0.03 (+0.43%)
At close: 4:00PM EDT

7.03 0.00 (0.00%)
After hours: 4:22PM EDT

Stock chart is not supported by your current browser
Previous Close7.00
Open7.09
Bid4.20 x 800
Ask13.50 x 1000
Day's Range6.91 - 7.10
52 Week Range3.63 - 13.50
Volume159,263
Avg. Volume324,401
Market Cap389.549M
Beta0.38
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GenMark Diagnostics Inc (NASDAQ:GNMK): Is Breakeven Near?
    Simply Wall St.15 hours ago

    GenMark Diagnostics Inc (NASDAQ:GNMK): Is Breakeven Near?

    GenMark Diagnostics Inc’s (NASDAQ:GNMK): GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. With the latest financial year lossRead More...

  • Thomson Reuters StreetEvents24 days ago

    Edited Transcript of GNMK earnings conference call or presentation 1-May-18 8:30pm GMT

    Q1 2018 GenMark Diagnostics Inc Earnings Call

  • Associated Press24 days ago

    GenMark Diagnostics: 1Q Earnings Snapshot

    On a per-share basis, the Carlsbad, California-based company said it had a loss of 21 cents. The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of GNMK earnings conference call or presentation 27-Feb-18 9:30pm GMT

    Q4 2017 GenMark Diagnostics Inc Earnings Call

  • Associated Press3 months ago

    GenMark Diagnostics reports 4Q loss

    The Carlsbad, California-based company said it had a loss of 26 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

  • 8 Stocks That Will Hit All-Time Lows in 2018
    InvestorPlace4 months ago

    8 Stocks That Will Hit All-Time Lows in 2018

    The world simply has moved away from Avon Products, Inc. (NYSE:AVP). The “Avon lady” that drove the U.S. business seems a relic of the past, and Avon already has sold that business to private equity firm Cerberus Capital Management.

  • Capital Cube6 months ago

    ETFs with exposure to GenMark Diagnostics, Inc. : November 21, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to GenMark Diagnostics, Inc. Here are 5 ETFs with the largest exposure to GNMK-US. Comparing the performance and risk of GenMark Diagnostics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Is GenMark Diagnostics Inc (GNMK) Undervalued?
    Simply Wall St.7 months ago

    Is GenMark Diagnostics Inc (GNMK) Undervalued?

    GenMark Diagnostics Inc (NASDAQ:GNMK), a healthcare equipment and supplies company based in United States, saw significant share price volatility over the past couple of months on the NasdaqGM, rising toRead More...

  • GenMark Diagnostics, Inc. :GNMK-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017
    Capital Cube8 months ago

    GenMark Diagnostics, Inc. :GNMK-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017

    Categories: Yahoo FinanceGet free summary analysis GenMark Diagnostics, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 12.36 million, Net Earnings of USD -17.99 million. Gross margins narrowed from 62.28% to 39.52% compared to the same period last year, operating (EBITDA) margins now -129.70% from -93.49%. Change in operating ... Read more (Read more...)

  • Thomson Reuters StreetEvents9 months ago

    Edited Transcript of GNMK earnings conference call or presentation 1-Aug-17 12:30pm GMT

    Q2 2017 GenMark Diagnostics Inc Earnings Call

  • Capital Cube10 months ago

    GenMark Diagnostics, Inc. – Value Analysis (NASDAQ:GNMK) : August 8, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives GenMark Diagnostics, Inc. a score of 25. Our analysis is based on comparing GenMark Diagnostics, Inc. with the following peers – QIAGEN NV, PerkinElmer, Inc., Alere Inc., Luminex Corp and Hologic, Inc. (QGEN-US, PKI-US, ALR-US, LMNX-US and HOLX-US). Investment Outlook GenMark Diagnostics, Inc. has a fundamental score ... Read more (Read more...)

  • Associated Press10 months ago

    GenMark Diagnostics reports 2Q loss

    On a per-share basis, the Carlsbad, California-based company said it had a loss of 37 cents. The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks ...

  • Capital Cube11 months ago

    GenMark Diagnostics, Inc. – Value Analysis (NASDAQ:GNMK) : June 12, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives GenMark Diagnostics, Inc. a score of 28. Our analysis is based on comparing GenMark Diagnostics, Inc. with the following peers – QIAGEN NV, PerkinElmer, Inc., Alere Inc., Luminex Corp and Hologic, Inc. (QGEN-US, PKI-US, ALR-US, LMNX-US and HOLX-US). Investment Outlook GenMark Diagnostics, Inc. has a fundamental score ... Read more (Read more...)

  • Cramer Remix: Ignoring Washington negatives could benefit...
    CNBC Videos2 months ago

    Cramer Remix: Ignoring Washington negatives could benefit...

    Jim Cramer reminds investors that when they focus on individual companies, good things can happen.